Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH

Reproductive BioMedicine Online

Volumn 24, Issue 4, 2012, Pages 410-419

  Tarlatzis, Basil C ^a   Griesinger, Georg ^b   Leader, Arthur ^c   Rombauts, Luk ^d   Ijzerman Boon, Pieta C ^e   Mannaerts, Bernadette M J L ^e  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c UNIVERSITY OF OTTAWA   (Canada)

^d MONASH IVF   (Australia)

^e MSD   (Netherlands)

Author keywords

assisted reproductive technology; corifollitropin alfa; gonadotrophin releasing hormone antagonist; OHSS; ovarian stimulation; recombinant FSH

Indexed keywords

CORIFOLLITROPIN ALFA; GONADORELIN; RECOMBINANT FOLLITROPIN; STEROID;

ABDOMINAL DISCOMFORT; ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADULT; ARTICLE; ASCITES; COMPARATIVE STUDY; CONTROLLED STUDY; DIARRHEA; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HOSPITALIZATION; HUMAN; INCIDENCE; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; NAUSEA; OOCYTE MATURATION; OOCYTE RETRIEVAL; OVARY CYST; OVARY HYPERSTIMULATION; OVARY HYPERTROPHY; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; STEROID RELEASE; VOMITING;

ADULT; CLINICAL TRIALS, PHASE III AS TOPIC; DOUBLE-BLIND METHOD; FEMALE; FERTILITY AGENTS, FEMALE; FOLLICLE STIMULATING HORMONE; FOLLICLE STIMULATING HORMONE, HUMAN; HUMANS; INCIDENCE; INFERTILITY; MULTICENTER STUDIES AS TOPIC; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOMBINANT PROTEINS;

EID: 84859430618     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2012.01.005     Document Type: Article

References (27)

1. M.M. Alper, L.P. Smith, and E.S. Sills Ovarian hyperstimulation syndrome: current views on pathophysiology, risk factors, prevention, and management J. Exp. Clin. Assist. Reprod. 6 2009 3
2. P.R. Brinsden, I. Wada, S.L. Tan, A. Balen, and H.S. Jacobs Diagnosis, prevention and management of ovarian hyperstimulation syndrome Br. J. Obstet. Gynaecol. 102 1995 767 772
3. Corifollitropin Alfa Ensure Study Group Corifollitropin alfa for ovarian stimulation in IVF: a randomized trial in lower-body-weight women Reprod. Biomed. Online 21 2010 66 76
4. R. De Greef, A.S. Zandvliet, A.F. de Haan, P.C. IJzerman-Boon, M. Marintcheva-Petrova, and B.M. Mannaerts Dose selection of corifollitropin alfa by modeling and simulation in controlled ovarian stimulation Clin. Pharmacol. Ther. 88 2010 79 87
5. A. Delvigne, and S. Rozenberg Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review Hum. Reprod. Update 8 2002 559 577 (Pubitemid 35452781)
6. A. Delvigne, and S. Rozenberg Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS) Hum. Reprod. Update 9 2003 77 96 (Pubitemid 36305585)
7. P. Devroey, R. Boostanfar, N.P. Koper, B.M. Mannaerts, P.C. IJzerman-Boon, B.C. Fauser on behalf of the ENGAGE Investigators A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol Hum. Reprod. 24 2009 3063 3072
8. P. Devroey, N.P. Polyzos, and C. Blockeel An OHSS-free clinic by segmentation of IVF treatment Hum. Reprod. 26 2011 2593 2597
9. I.J. Duijkers, C. Klipping, P.J. Boerrigter, C.S. Machielsen, J.J. De Bie, and G. Voortman Single dose pharmacokinetics and effects on follicular growth and serum hormones of a long-acting recombinant FSH preparation (FSH-CTP) in healthy pituitary-suppressed females Hum. Reprod. 17 2002 1987 1993
10. L. Engmann, A. DiLuigi, D. Schmidt, J. Nulsen, D. Maier, and C. Benadiva The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study Fertil. Steril. 89 2008 84 91
11. B.C. Fauser, M.M. Alper, W. Ledger, W.B. Schoolcraft, A. Zandvliet, B.M. Mannaerts for the Engage Investigators Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF Reprod. Biomed. Online 21 2010 593 601
12. H.M. Fatemi, J. Oberyé, B. Popovic-Todorovic, H. Witjes, B.M.J.L. Mannaerts, and P. Devroey Corifollitropin alfa in a long GnRH agonist protocol: proof of concept trial Fertil. Steril. 94 2010 389 400
13. A. Golan, and A. Weissman Symposium: update on prediction and management of OHSS. A modern classification of OHSS Reprod. Biomed. Online 19 2009 28 32
14. G. Griesinger, L. Schultz, T. Bauer, A. Broessner, T. Frambach, and S. Kissler Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin- releasing hormone antagonist protocol in combination with a "freeze- all" strategy: a prospective multicentric study Fertil. Steril. 95 2011 2029 2033
15. P. Humaidan, H. Ejdrup Bredkjaer, L.G. Westergaard, and C. Yding Andersen 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study Fertil. Steril. 93 2010 847 854
16. P. Humaidan, J. Quartarolo, and E.G. Papanikolaou Preventing ovarian hyperstimulation syndrome: guidance for the clinician Fertil. Steril. 94 2010 389 400
17. E.M. Kolibianakis, J. Collins, B.C. Tarlatzis, P. Devroey, K. Diedrich, and G. Griesinger Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis Hum. Reprod. Update 12 2006 651 671 (Pubitemid 44605507)
18. J. Kwee, M.E. Elting, R. Schats, J. McDonnell, and C.B. Lambalk Ovarian volume and antral follicle count for the prediction of low and hyper responders with in vitro fertilization Reprod. Biol. Endocrinol 5 2007 9
19. W.L. Ledger, B.C. Fauser, P. Devroey, A.S. Zandvliet, and B.M. Mannaerts Corifollitropin alfa doses based on body weight: clinical overview of drug exposure and ovarian response Reprod. Biomed. Online 23 2011 150 159
20. T.H. Lee, C.H. Liu, C.C. Huang, Y.L. Wu, Y.T. Shih, H.N. Ho, Y.S. Yang, and M.S. Lee Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles Hum. Reprod. 23 2008 160 167
21. C.A. Lyons, C.A. Wheeler, G.N. Frishman, R.J. Hackett, D.B. Seifer, and R.V. Haning Jr. Early and late presentation of the ovarian hyperstimulation syndrome: two distinct entities with different risk factors Hum. Reprod. 9 1994 792 799 (Pubitemid 24168060)
22. R.S. Mathur, V.A. Akande, S.D. Keay, L.P. Hunt, and J.M. Jenkins Distinction between early and late ovarian hyperstimulation syndrome Fertil. Steril. 73 2000 901 907 (Pubitemid 30227512)
23. R.J. Norman, F. Zegers-Hochschild, B.S. Salle, J. Elbers, E. Heijnen, M. Marintcheva-Petrova, B. Mannaerts Trust Investigators Repeated ovarian stimulation with corifollitropin alfa in patients in a GnRH antagonist protocol: no concern for immunogenicity Hum. Reprod. 26 2011 2200 2208
24. E.G. Papanikolaou, C. Pozzobon, and E.M. Kolibianakis Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles Fertil. Steril. 85 2006 112 120 (Pubitemid 43063432)
25. T.E. Verhagen, D.J. Hendriks, L.F. Bancsi, B.W. Mol, and F.J. Broekmans The accuracy of multivariate models predicting ovarian reserve and pregnancy after in vitro fertilization: a meta-analysis Hum. Reprod. Update 14 2008 95 100 (Pubitemid 351321105)
26. G.R. Verwoerd, T. Mathews, and P.R. Brinsden Optimal follicle and oocyte numbers for cryopreservation of all embryos in IVF cycles at risk of OHSS Reprod. Biomed. Online 17 2008 312 317
27. WHO Scientific Group, 1973. Report. World Health Organization, Geneva.